Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache

Abstract

Our results support the emerging evidence that anti-CGRP monoclonal antibodies may be effective in medication overuse headache patients irrespective of detoxification, yet further studies are needed to draw definitive conclusions.